Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 8 studies | 30% ± 14% | |
oligodendrocyte | 8 studies | 27% ± 9% | |
endothelial cell | 7 studies | 24% ± 6% | |
retinal cone cell | 7 studies | 44% ± 18% | |
type II pneumocyte | 6 studies | 26% ± 8% | |
oligodendrocyte precursor cell | 6 studies | 31% ± 13% | |
microglial cell | 5 studies | 26% ± 6% | |
macrophage | 5 studies | 24% ± 9% | |
B cell | 4 studies | 26% ± 2% | |
naive B cell | 4 studies | 19% ± 1% | |
GABAergic neuron | 4 studies | 40% ± 10% | |
endothelial cell of lymphatic vessel | 4 studies | 21% ± 7% | |
type I pneumocyte | 4 studies | 20% ± 3% | |
epithelial cell | 3 studies | 25% ± 6% | |
ciliated cell | 3 studies | 24% ± 7% | |
retinal rod cell | 3 studies | 23% ± 5% | |
hepatocyte | 3 studies | 31% ± 10% | |
glutamatergic neuron | 3 studies | 53% ± 5% | |
club cell | 3 studies | 23% ± 7% | |
fibroblast | 3 studies | 21% ± 5% | |
adipocyte | 3 studies | 20% ± 2% | |
neuron | 3 studies | 30% ± 10% | |
interneuron | 3 studies | 40% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2530.73 | 2642 / 2642 | 100% | 29.22 | 705 / 705 |
prostate | 100% | 1861.04 | 245 / 245 | 100% | 11.12 | 501 / 502 |
lung | 100% | 2265.48 | 578 / 578 | 100% | 12.43 | 1152 / 1155 |
adrenal gland | 100% | 3513.24 | 258 / 258 | 100% | 16.71 | 229 / 230 |
thymus | 100% | 2866.66 | 653 / 653 | 100% | 14.31 | 602 / 605 |
kidney | 100% | 1597.13 | 89 / 89 | 99% | 13.60 | 895 / 901 |
breast | 100% | 2215.93 | 459 / 459 | 99% | 19.92 | 1110 / 1118 |
liver | 100% | 2433.07 | 226 / 226 | 99% | 11.59 | 403 / 406 |
esophagus | 100% | 1747.42 | 1445 / 1445 | 99% | 8.33 | 181 / 183 |
pancreas | 100% | 1132.61 | 328 / 328 | 98% | 11.03 | 175 / 178 |
stomach | 100% | 1612.71 | 359 / 359 | 97% | 7.98 | 278 / 286 |
uterus | 100% | 2782.62 | 170 / 170 | 97% | 9.76 | 445 / 459 |
bladder | 100% | 2001.57 | 21 / 21 | 97% | 7.86 | 487 / 504 |
intestine | 100% | 2116.28 | 966 / 966 | 96% | 8.04 | 508 / 527 |
skin | 100% | 1417.70 | 1808 / 1809 | 95% | 11.72 | 448 / 472 |
ovary | 100% | 1929.84 | 180 / 180 | 95% | 7.31 | 407 / 430 |
adipose | 100% | 1947.52 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2443.02 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 3622.05 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2157.39 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.45 | 1 / 1 |
heart | 98% | 1393.13 | 845 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 8.55 | 44 / 45 |
lymph node | 0% | 0 | 0 / 0 | 97% | 7.40 | 28 / 29 |
peripheral blood | 88% | 847.45 | 813 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 81% | 6.79 | 65 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1903012 | Biological process | positive regulation of bone development |
GO_0001503 | Biological process | ossification |
GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
GO_0048706 | Biological process | embryonic skeletal system development |
GO_0045724 | Biological process | positive regulation of cilium assembly |
GO_0030030 | Biological process | cell projection organization |
GO_0051216 | Biological process | cartilage development |
GO_0061036 | Biological process | positive regulation of cartilage development |
GO_0014032 | Biological process | neural crest cell development |
GO_0005813 | Cellular component | centrosome |
GO_0036064 | Cellular component | ciliary basal body |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0016520 | Molecular function | growth hormone-releasing hormone receptor activity |
Gene name | TAPT1 |
Protein name | Transmembrane anterior posterior transformation 1 Transmembrane anterior posterior transformation protein 1 homolog (Cytomegalovirus partial fusion receptor) |
Synonyms | CMVFR |
Description | FUNCTION: Plays a role in primary cilia formation . May act as a downstream effector of HOXC8 possibly by transducing or transmitting extracellular information required for axial skeletal patterning during development (By similarity). May be involved in cartilage and bone development (By similarity). May play a role in the differentiation of cranial neural crest cells (By similarity). .; FUNCTION: (Microbial infection) In case of infection, may act as a fusion receptor for cytomegalovirus (HCMV) strain AD169. . |
Accessions | ENST00000513782.1 ENST00000505603.5 D6RBK3 Q6NXT6 H0Y916 ENST00000405303.7 [Q6NXT6-1] ENST00000513833.1 H0Y985 |